Blood pressure, diabetes and diabetic nephropathy

Diabetes and Metabolism

Volumn 26, Issue SUPPL. 4, 2000, Pages 37-44

  Chantrel, F ^a   Moulin, B ^a   Hannedouche, T ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

ACE inhibitors; Beta blockers; Diabetes; Diuretics; Hypertension

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FUROSEMIDE; NISOLDIPINE; RAMIPRIL; VERAPAMIL;

ANTIHYPERTENSIVE ACTIVITY; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CONFERENCE PAPER; CORONARY ARTERY DISEASE; CREATININE CLEARANCE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; EVIDENCE BASED MEDICINE; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY TUBULE ABSORPTION; PRIMARY PREVENTION;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; DIURETICS; HUMANS; HYPERTENSION;

EID: 0033854845     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (17)

1. Keller CK, Bergis KH, Fliser D, Ritz E. Renal findings in patients with short-term type 2 diabetes. J Am Soc Nephrol, 1996, 7(12), 2627-2635.
2. US Renal Data System. USRDS 1997 Annual Data Report, Bethesda, MD, The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 1997.
3. Ismail N, Becker B, Strzelczyk P, Ritz E. Renal disease and hypertension in non-insulin-dependent diabetes mellitus. Kidney Int, 1999, 55(1), 1-28.
4. Ritz E, Rychlik I, Locatelli F, Halimi S. End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions20[In Process Citation]. Am J Kidney Dis, 1999, 34(5), 795-808.
5. Breyer JA, Bain RP, Evans JK, et al. Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. The Collaborative Study Group. Kidney Int, 1996, 50(5), 1651-1658.
6. Rossing P, Hougaard P, Borch-Johnsen K, Parving HH. Predictors of mortality in insulin dependent diabetes: 10 year observational follow-up study. BMJ, 1996, 313(7060), 779-784.
7. Hansson L, Zanchetti A, Carruthers SG, et al. Effects of blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet, 1998, 351, 1755-1762.
8. Tuomilehto J, Rastenyte D, Birkenhager WH, et al. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators. N Engl J Med, 1999, 340(9), 677-684.
9. Mogensen CE, Hansen KW, Pedersen MM, Christensen CK. Renal factors influencing blood pressure threshold and choice of treatment for hypertension in IDDM. Diabetes Care, 1991, 14 (Suppl 4), 13-26.
10. Parving HH, Smidt UM, Hommel E, et al. Effective antihypertensive treatment postpones renal insufficiency in diabetic nephropathy. Am J Kidney Dis, 1993, 22(1), 188-195.
11. Trocha AK, Schmidtke C, Didjurgeit U, et al. Effects of intensified antihypertensive treatment in diabetic nephropathy: mortality and morbidity results of a prospective controlled 10-year study. J Hypertens, 1999, 17(10), 1497-1503.
12. Hasslacher C, Wolfrum M, Stech G, Wahl P, Ritz E. [Diabetic nephropathy in type II diabetes: effect of metabolic control and blood pressure on its development and course]. Dtsch Med Wochenschr, 1987, 112(38), 1445-1449.
13. Biesenbach G, Zazgomik J. High Mortality and Poor Quality of life during Predialysis Period in Type II Diabetic Patients with Diabetic Nephropathy. Ren Fail, 1994, 16(2), 263-272.
14. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group [see comments] [published erratum appears in BMJ 1999 Jan 2; 318(7175): 29]. BMJ, 1998, 317(7160), 703-713.
15. Schrier RW, Estacio RO, Jeffers B. Appropriate Blood Pressure Control in NIDDM (ABCD) Trial. Diabetologia, 1996, 39(12), 1646-1654.
16. Ruggenenti P, Remuzzi G. Primary prevention of renal failure in diabetic patients: the Bergamo Nephrologic Diabetes Complication Trial. J Hypertens, Suppl 1998, 16(1), S95-S97.
17. Gaede P, Vedel P, Parving HH, Pedersen O. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study [see comments]. Lancet, 1999, 353, 617-622.